Molecular Mechanisms of Endothelial Dysfunction in Type 2 Diabetes Mellitus.
Phase of Trial: Phase IV
Latest Information Update: 09 Jun 2013
At a glance
- Drugs Meglitinide; Pioglitazone; Sulfonylureas
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 30 May 2012 Actual initiation date (Mar 2007), trial company, lead trial centres and investigator a added as reported by ClinicalTrials.gov.
- 30 May 2012 Actual end date (Nov 2008) added as reported by ClinicalTrials.gov.
- 30 May 2012 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health: NCT00816218).
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History